Dicyclomine Hydrochloride NDC 73473-902

NDC codes

FDA NDC Directory

Product NDC (as listed)73473-902Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73473-0902Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73473-902-01	73473090201	100 TABLET in 1 BOTTLE (73473-902-01)Marketed from Jun 10, 2025
73473-902-10	73473090210	1000 TABLET in 1 BOTTLE (73473-902-10)Marketed from Jun 10, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Dicyclomine Hydrochloride
Generic name (nonproprietary): dicyclomine hydrochloride
Active ingredients: Dicyclomine hydrochloride — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Solaris Pharma Corporation
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216760
Marketing start: Jun 10, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Cholinergic Antagonists (Mechanism)
Identifiers: Product ID 73473-902_98b3a053-2708-460d-9929-d89164cd4a49SPL ID 98b3a053-2708-460d-9929-d89164cd4a49SPL set ID d46259e6-5eca-4356-bc18-815104c925ccRxCUI 991086UNII CQ903KQA31UPC 0373473902103, 0373473902011
Pharmacologic class: Anticholinergic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473473090201 followed by a unit qualifier and the quantity

Package 73473-0902-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 11, 2025.

Indications (excerpt from the label)

Dicyclomine hydrochloride is indicated for the treatment of patients with functional bowel/irritable bowel syndrome. Dicyclomine hydrochloride is an antispasmodic and anticholinergic (antimuscarinic) agent indicated for the treatment of functional bowel/irritable bowel syndrome (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 216760

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216760
Product	Strength	Form · route	Labeler	Product NDC
Dicyclomine hydrochloride	Dicyclomine hydrochloride 20 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	0832-6052
Dicyclomine Hydrochloride	Dicyclomine hydrochloride 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-539